Sponsored by:

Molecular Imaging: Page 273

Collaboration among specialties enhances prospects of cancer patients
By Becky McCall
VIENNA - Promoting more effective collaboration among radiologists, nuclear medicine physicians, and radiation oncologists to improve imaging and radiotherapy outcomes is a core principle underpinning the lectures in a special focus session on Friday at ECR 2013.
March 7, 2013
2013 03 06 13 03 52 101 2013 03 08 Cancer Thumb
FDG-PET/MRI 'comparable' to FDG-PET/CT in head/neck cancer
By Wayne Forrest
VIENNA - FDG-PET/MRI can produce diagnostic quality images "comparable" to FDG-PET/CT in patients with head and neck cancer, according to a study presented on Thursday during the opening day of ECR 2013.
March 6, 2013
European experts urge caution on PET/MRI use
By Rebekah Moan
VIENNA - "Hold your horses" was the main message regarding PET/MRI at Thursday's ECR 2013 opening press conference. People may want to quickly adopt the fairly new technique, but Dr. Heinz-Peter Schlemmer of the German Cancer Research Center in Heidelberg urged caution.
March 6, 2013
2013 03 07 10 38 33 608 2013 03 07 Schlemmer 70
Navidea posts Q4, year-end results
By AuntMinnie.com staff writers
Radiopharmaceutical developer Navidea Biopharmaceuticals has released its fourth quarter and 2012 fiscal year financial results.
March 6, 2013
US elastography, contrast-enhanced mammography, MR spectroscopy: Which offers the most promise?
By Rebekah Moan
VIENNA - Mammography is an imperfect modality, so it makes sense that radiologists are on the lookout for something better, or at least something to supplement the technique. Thursday's refresher course covers functional imaging of the breast and goes into detail about ultrasound elastography, contrast-enhanced mammography, and MRI diffusion, perfusion, and spectroscopy, which may supplement mammography or replace it altogether.
March 6, 2013
2013 02 28 16 29 51 583 2013 03 07 Breast Thumb
Molecular advances boost evaluation of cancer treatment response
By Becky McCall
VIENNA - Advances in molecular imaging promise to make it realistic to identify differences in response of cancer cells to a specific treatment, and this information will eventually be used to better adapt therapies to a patient's specific needs.
March 6, 2013
2013 02 27 12 21 32 769 2013 03 07 Pet Thumb
Lantheus appoints new chief medical officer
By AuntMinnie.com staff writers
Diagnostic imaging agent developer Lantheus Medical Imaging said it has appointed a new chief medical officer.
March 5, 2013
Mo-99 price decreases affect Nordion's Q1 bottom line
By AuntMinnie.com staff writers
Decreases in the price of molybdenum-99 (Mo-99) adversely affected Nordion's medical isotope business in the company's first quarter of fiscal 2013.
March 5, 2013
Study shows decline in abnormal stress SPECT MPI
By Wayne Forrest
Over the past two decades, the frequency and severity of abnormal stress SPECT myocardial perfusion imaging (MPI) studies have significantly decreased, with the prevalence of abnormal SPECT exams falling from 40.9% to 8.7%, researchers reported in the March 5 issue of the Journal of the American College of Cardiology.
March 5, 2013
Bayer signs Intego PET distribution deal
By AuntMinnie.com staff writers
Bayer HealthCare has signed a distribution agreement for its Medrad Intego PET infusion system with Italian protection technology firm Comecer.
March 4, 2013
Digirad to restructure, make executive changes
By AuntMinnie.com staff writers
Nuclear medicine firm Digirad has unveiled plans to restructure the company and make management changes in the wake of its 2012 year-end financial report.
February 27, 2013
AECL nuclear operations go up for bid
By AuntMinnie.com staff writers
The Canadian government plans to solicit bids from private companies to operate Atomic Energy of Canada's (AECL) nuclear laboratories in Chalk River, Ontario.
February 27, 2013
Previous Page
Page 273 of 612
Next Page